Is This Heavily Shorted Stock Set To Squeeze Bears?
Despite succeeding in the rough and tumble world of HR management, one particular firm has also become one of the most heavily shorted stocks in the market.
Yet beneath the surface, there are signals that the stock could be on the verge of a sharp rebound—perhaps even a short squeeze that will catch many off guard. » Read more about: Is This Heavily Shorted Stock Set To Squeeze Bears? »
Read More
Market Commentary: What’s Inside Buffett’s Portfolio?
In its latest 13F filing, Berkshire Hathaway bought and sold some stocks that paint a clear picture of what Buffett thinks the future of the economy will look like. Some old favorites he left untouched while others he sold off with abandon. Yet other stocks, he accumulated in spades.
What is Buffett buying and selling now?
» Read more about: Market Commentary: What’s Inside Buffett’s Portfolio? »
Read More
Market Commentary: The Meteoric Rise of Eli Lilly
Did you know that Eli Lilly and other pharmaceutical companies have sold approximately 10.6 million shots of obesity drug doses in the U.S. in a single month? The rise of these injectable weight loss medications is so powerful that it’s causing investors to question the future of even staple food and beverage stocks.
While this aspect alone could secure Eli Lilly as the pharmaceutical golden goose you’ve been looking for there is much more than meets the eye.
» Read more about: Market Commentary: The Meteoric Rise of Eli Lilly »
Read More
Market Commentary: $25 Billion Stock On Sale 90% Lower?
One of Warren Buffett’s old favorites, Brazil’s StoneCo, has emerged with a strategy that may create a U-turn in it share price. What was once a $25 billion company has crashed to just $3 billion and change in market capitalization.
Yet StoneCo hasn’t been knocked out for the count yet. It surprised investors with an announcement that signaled it was bullish on its own company via a R$300 million (approximately $58.2 million) share repurchase program.
» Read more about: Market Commentary: $25 Billion Stock On Sale 90% Lower? »
Read More
What Price Exactly Should Palantir Trade At?
Palantir Technologies (NYSE:PLTR) has successfully ridden the AI wave of the last two years to produce outstanding shareholder returns.
The stock traded at less than $7 as recently as the beginning of 2023 but has since risen by over 6x. This sudden spike in prices begs the question of whether the market is valuing Palantir appropriately today.
» Read more about: What Price Exactly Should Palantir Trade At? »
Read MoreThe Ivy
Is The Santa Claus Rally Real?
Every seasoned trader has heard the phrase “Santa Claus Rally,” but very few understand precisely why it happens. Is it random or is there something structural under the surface that repeats like clockwork each year?
Beyond the whimsical idea of holiday cheer spilling over into the markets, there are structural and behavioral dynamics at play that make the final weeks of the year particularly conducive to market gains.
» Read more about: Is The Santa Claus Rally Real? »
Read MoreThe Spotlight
Chipotle’s Sizzling Success Fueling Unstoppable Growth
Chipotle Mexican Grill continues to thrive in the fast-casual dining sector, surpassing expectations despite facing tough year-over-year revenue comparisons.
The burrito chain not only maintained its growth trajectory but accelerated it, translating to a 14.1% increase year over year to $2.7 billion in Q1 2024. The growth is particularly impressive given that it follows a 17.2% increase in the same quarter last year.
» Read more about: Chipotle’s Sizzling Success Fueling Unstoppable Growth »
Read MoreThe Daily
Americans give a verdict on Trump’s tariff and economic policies; his ratings are at…
US President Donald Trump saw approval ratings hit a new low this month amid an escalating trade war and continued recession fears. A growing percentage of the population has turned against the Republican leader within his first 100 days in office — with a sharp turn toward pessimism about the stock market.